Showing 11,021 - 11,040 results of 102,308 for search '(( 5 ((teer decrease) OR (a decrease)) ) OR ( 50 ((mean decrease) OR (nn decrease)) ))', query time: 1.72s Refine Results
  1. 11021

    <i>Srpr</i> is a direct target of miR-330-5p in mouse keratinocyte. by Bong-Kyu Kim (3235107)

    Published 2016
    “…<p>(A) Location of the binding site for miR-330-5p in 3’UTR of <i>Srpr</i> mRNA. …”
  2. 11022
  3. 11023
  4. 11024
  5. 11025
  6. 11026
  7. 11027
  8. 11028
  9. 11029
  10. 11030

    Fig4 Btk is a downstream target gene of miR-185-5p.tif by Dan He (14029722)

    Published 2022
    “…(B) In the dual-luciferase report experiment, the fluorescence decreased after overexpression of miR-185-5p and transfection of PsiCHECK2-Btk-3'UTR wild-type plasmid. …”
  11. 11031
  12. 11032
  13. 11033
  14. 11034

    Rab1A knockdown exacerbated stress damage due to serum depletion and 5-FU treatment. by Masako Tanaka (560084)

    Published 2014
    “…<p>HT29 cells transfected with <i>Hsc70</i>, <i>Rab1A</i>, or <i>control</i> siRNA were subjected to serum depletion, 5-FU, or vehicle treatment for 24 h. …”
  15. 11035

    Average relative abundance change of five most abundant families in a gut simulator treated with salicylate. by Kathleen O’Connor (3920027)

    Published 2019
    “…<p>A gut simulator seeded with a human gut microbiota was treated with salicylate each day for five days at at 0.01 mg/mL (0.01X MIC, red), 0.1 mg/mL (0.1X MIC, green) and 1 mg/mL (1X MIC, purple). …”
  16. 11036

    Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 and -1 by Piali Mukherjee (86993)

    Published 2011
    “…GluR2 immunoreactivity was quantitated from 8–10 randomly selected fields and results were expressed as a percent of vehicle treated WT controls. KA significantly decreased the expression of GluR2 immunoreactivity in the mossy fiber region of C5aRKO mice (Fig. …”
  17. 11037
  18. 11038
  19. 11039
  20. 11040

    Analysis of dLGN reduction and <i>ephrin A5</i> expression in control and enucleated brains. by Olga O. Kozanian (811729)

    Published 2015
    “…(D) Area of <i>ephrin A5</i> expression in P4 dLGN. Percentage of <i>ephrin A5</i> expression in enucleated dLGN (73.52 ± 6.190%; <i>P</i> < 0.01) is significantly different when compared to controls. …”